SCHEMBL28626686

SCHEMBL28626686

COCOc1cc(Cl)c(OC)c(C=O)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 1/20 0.40
ERN1 O75460 6/20 0.39
ALDH1A1 P00352 5/20 0.37
ORAI1 Q96D31 1/20 0.36
CYP1A2 P05177 2/20 0.35
KDM4E B2RXH2 2/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
BACE1 P56817 1/20 0.33
MCL1 Q07820 1/20 0.33
TRIM24 O15164 1/20 0.33
TYR P14679 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CYP3A4 P08684 1/20 0.32
PKM P14618 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505232 0.80 ALDH1A1 (0.39) TUBB1ERN1ALDH1A1ORAI1CYP1A2
SCHEMBL3152062 0.79 PRKDC (0.42) TUBB1ERN1ALDH1A1CYP1A2KDM4E
SCHEMBL4497582 0.79 TUBB1 (0.50) TUBB1ERN1ALDH1A1TDP1
SCHEMBL24132612 0.78 ALDH1A1 (0.38) ERN1ALDH1A1CYP1A2TDP1BACE1
SCHEMBL28624223 0.78 PRKDC (0.41) TUBB1ERN1ALDH1A1CYP1A2KDM4E
SCHEMBL3222717 0.78 ORAI1 (0.49) ERN1ALDH1A1ORAI1CYP1A2KDM4E
SCHEMBL31471572 0.78 TDP1 (0.47) TUBB1ERN1ALDH1A1CYP1A2KDM4E
SCHEMBL30664028 0.76 LMNA (0.46) TUBB1ERN1ALDH1A1CYP1A2CYP2C19
SCHEMBL28613482 0.76 LMNA (0.46) TUBB1ERN1ALDH1A1CYP1A2CYP2C19
SCHEMBL31715172 0.75 CYP1A2 (0.42) ERN1ALDH1A1ORAI1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113301959-A Substituted chromen-4-ones for the treatment and prevention of hepatitis B virus infection 豪夫迈·罗氏有限公司 2021-08-24 CN disclosed